Every compounded program and lab panel available to FMFT prescribers, including those still to launch. Work through the three steps below and the finder ranks a best fit for each goal.
All prescribing decisions stay with you.
Pick one or more. With several, results follow the order you pick them in.
Flags any program with a caution for these. Nothing is hidden.
Some programs are tier-gated or not yet orderable.
How the blocks connect: titration sequences where order matters, and side-by-side choices where it doesn't. Numbered paths run in sequence.
Every program in the catalog, grouped by category, with its supplied schedule and availability. Select one for clinical context and screening.
Five panels covering baseline and monitoring. The matrix shows exactly which markers each one includes, so you can pick the lightest panel that answers your question.
Programs marked coming soon are not orderable yet, so plan around them rather than promising a patient a date. Programs marked for the Growth and Scale tiers depend on your partner tier; confirm yours before building a plan on them.
These are compounded preparations. They are not FDA-approved products, and compounding eligibility for some agents, peptides in particular, changed more than once during 2026. Confirm current eligibility with the pharmacy before prescribing. Where a commercial equivalent exists, be clear with yourself about why the compounded version is the clinical choice.
Flags aggregate the standard cautions for each agent class. A flag means review before prescribing, unless the wording says contraindicated or avoid. Absence of a flag is not clearance: it means this reference holds no category-specific caution for that combination.
These statements have not been evaluated by the Food and Drug Administration. These programs are not intended to diagnose, treat, cure, or prevent any disease. Results may vary.
This reference is for licensed medical providers, authorised medical facilities, or entities operating under a provider's medical license. The prescriber accepts full responsibility for handling, storage, administration and use in line with their licensure, local regulations and internal standards. All prescribing decisions remain with the treating provider.